Skip to main content
OpenTrials
Completed

NCT Number: NCT05449652

Exercise Prescriptions for Patients With Cardiovascular Disease

Physiotherapists are often confronted with patients with (elevated risk for) cardiovascular disease (CVD), even when this is not the primary indication for physiotherapy. Hence, physiotherapists should be able to provide evidence-based exercise advice to these patients, but this has not been assessed. The aim of this study was therefore to assess whether exercise prescriptions by physiotherapists to patients with CVD are in accordance with international recommendations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Hasselt University

Diepenbeek, Limburg, 3590, Belgium

About this study

In this prospective observational survey, forty-seven Belgian physiotherapists agreed to prescribe exercise intensity, frequency, session duration, program duration, and exercise type (endurance or strength training) for the same three patient cases. Exercise prescriptions were compared between clinicians and relations with clinician characteristics were studied. In addition, the agreement between physiotherapists' exercise prescriptions and those from international recommendations (based on a maximal score of 60/per case) was assessed.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Currently professionally active Flemish physiotherapists

Exclusion criteria

Not having access to a device that allows the use of the EXercise Prescription in Everyday practice & Rehabilitative Training (EXPERT) tool.

Treatment and study plan

To prescribe exercise prescription for CVD patients

Other

To prescribe exercise intensity, frequency, session duration, program duration, and exercise type (endurance or strength training) for the same three patient cases

Primary outcomes

  1. Exercise intensity

    Time frame: February - April 2022

    Assessment of the prescription of exercise intensity (expressed in heart rate in beats per minute)

  2. Exercise frequency

    Time frame: February - April 2022

    Assessment of exercise frequency (expressed in number of exercise sessions per week)

  3. Session duration

    Time frame: February - April 2022

    Assessment of session duration (expressed in number of minutes)

  4. Program duration

    Time frame: February - April 2022

    Assessment of program duration (expressed in number of weeks)

  5. Exercise type

    Time frame: February - April 2022

    Aerobic exercise or strength exercise

  6. Total exercise volume

    Time frame: February - April 2022

    Multiplication of number of prescribed weeks, number of prescribed sessions/week, prescribed individual session duration and prescribed exercise intensity

Secondary outcomes

  1. Association between exercise prescriptions and clinician characteristics'

    Time frame: February - April 2022

    Relations between exercise prescriptions (intensity, frequency, session/program duration, exercise type) and clinician characteristics (age, gender, education, experience,...) were studied.

Sponsors and collaborators

Lead sponsor

Hasselt University

Other

Registry information

Official study title

Are Exercise Prescriptions for Patients With Cardiovascular Disease, Made by Physiotherapists, in Agreement With International Guidelines?

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jul 8, 2022
Registry last updated
Jul 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.